ArticleFrontiers in cardiovascular medicine2026
Red blood cell distribution width to albumin ratio predicts mortality in heart failure patients with pneumonia.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure (HF) patients with pneumonia admitted to the intensive care unit (ICU) face high mortality risks, yet current risk stratification tools lack precision. This study aims to evaluate the prognostic value of the red blood cell distribution width to albumin ratio (RAR) and develop a machine learning model for predicting 31-day in-hospital mortality in HF patients with pneumonia in ICU. Methods: We included the MIMIC-IV cohort and an external validation cohort from the First Affiliated Hospital of Zhengzhou University. The restricted cubic spline (RCS), Kaplan-Meier, and multivariable Cox regression analyses were used to estimate the RAR's prognostic value for 31-day in-hospital mortality. Boruta-selected features were used to build eight machine learning models. Results: In the Medical Information Mart for Intensive Care -IV (MIMIC-IV) cohort ( Conclusions: This study identifies RAR as an effective prediction biomarker for HF patients with pneumonia and provides a clinical tool for precise risk profiling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.